Skip to search formSkip to main contentSkip to account menu

desmethylselegiline

Known as: demethyl-deprenyl-DMD, di-N-propargylamphetamine, N-desmethyl-selegiline 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Selegiline ([R]-[-]N,alpha-dimethyl-N-2- propynylphenethylamine or l-deprenyl), an irreversible inhibitor of monoamine oxidase… 
2001
2001
Abstract. Objective: To characterise the effects of itraconazole, a potent inhibitor of CYP3A4, on the pharmacokinetics of… 
2001
2001
Cytochromes P450 (P450, CYP) are a superfamily of enzymes that participate especially in the oxidative metabolism of various… 
2001
2001
Abstract. Objectives: To address the relevance of cytochrome P-450 (CYP) 2C19 polymorphism for the pharmacokinetics and dynamics… 
2000
1999
1999
SummaryRats were treated with either (−)- or (+)-deprenyl, and the metabolites extracted from the plasma, liver, kidney and heart… 
1996
1996
AbstractPurpose. The absorption and disposition of selegiline (SEL) and its metabolites N-desmethylselegiline (DMS), L… 
1996
1996
The bioavailability of two selegiline HCl (CAS 14611-52-0) tablet products was compared in a single-blind, single-dose…